Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

April 26, 2015 6:57 PM ET

Life Sciences Tools and Services

Company Overview of ShangPharma Corporation

Company Overview

ShangPharma Corporation, through its subsidiaries, operates as a pharmaceutical and biotechnology research and development outsourcing company. It offers various integrated services across the drug discovery and development process to international and Chinese pharmaceutical and biotechnology companies, and academic and research institutions. The company’s services include discovery chemistry, discovery biology and preclinical development, pharmaceutical development, and biologics services. Its discovery chemistry services consist of medicinal chemistry, synthetic chemistry, library generation, and analytical chemistry; and discovery biology and preclinical development services comprise assa...

No 5 Building 998 Halei Road

Zhangjiang Hi-Tech Park Pudong New Area

Shanghai,  201203


Founded in 2002

2,076 Employees


86 21 5132 0088


86 21 5132 0110

Key Executives for ShangPharma Corporation

Founder, Chairman of The Board and Chief Executive Officer
Age: 43
President and Chief Scientific Officer
Chief Financial Officer
Age: 50
Chief Biologics Officer
Age: 48
Compensation as of Fiscal Year 2014.

ShangPharma Corporation Key Developments

ShangPharma Corporation Appoints Mitchell Reff as Chief Biologics Officer

ShangPharma Corporation announced that Dr. Mitchell Reff has joined the company as Chief Biologics Officer. He joined Idec Pharmaceuticals as head of molecular biology in 1990. Dr. Reff had a distinguished 21 year career at Idec, and later at Biogen Idec. He was Vice President Discovery Oncology at Biogen Idec running multiple bicoastal oncology groups developing small molecule and recombinant protein therapeutic molecules for oncology and delivered 6 novel oncology drugs into clinical trials in 5 years. Dr. Reff is well-recognized in the pharmaceutical and research community having been listed as an inventor on approximately 29 patents and patent applications, and as an author in nearly 100 scientific publications and presentations.

ShangPharma Corporation Appoints Art Taveras as President and Chief Scientific Officer

ShangPharma Corporation announced that Dr. Art Taveras will join the company as President and Chief Scientific Officer (CSO). As President and CSO, Dr. Taveras will establish the company as the premiere Drug Discovery and Development partner of Pharmaceutical and Biotechnology companies worldwide. Prior to joining the company, Dr. Taveras was Vice President Small Molecules Drug Discovery, Vice President Chemistry R&D, and Vice President CMC Development at Biogen Idec. Prior to joining ShangPharma, Dr. Taveras was Vice President Small Molecules Drug Discovery, Vice President Chemistry R&D, and Vice President CMC Development at Biogen Idec, leading the discovery and CMC development of neurology, immunology and oncology drug candidates at its multiple sites and partnerships in the U.S. and abroad. Before Biogen Idec, Dr. Taveras was Vice President of Drug Discovery and CMC Development at Alantos Pharmaceuticals.

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ShangPharma Corporation, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at